Network is a verb. The experience of the network of community-oriented educational institutions for health sciences.

The process of networking has great potential for facilitating and accelerating global health development. This article presents some of the experiences of the Network of Community-Oriented Educational Institutions for Health Sciences. Three components are identified, each of which is illustrated by a specific Network activity: (1) tasks and projects, (2) information and communications technology, (3) people and institutions--the human factor. Some important lessons have been learned. Because people are the key to successful networking, there is a need to strengthen the research about how networks function. Encouraging progress is being made toward more effective global collaboration.

Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.

We have investigated the therapeutic efficacy of a single injection of 131I-labeled murine mouse monoclonal antibody (NP-4) against carcinoembryonic antigen using the human colonic tumor xenograft, GW-39, grown in the cheek pouches of adult hamsters. Therapeutic efficacy was dependent on the dose of radioactivity, the specificity of the antibody for the tumor, and the size of the tumor when the radioantibody was administered. A dose of 1 mCi of 131I-labeled NP-4 given 1 day after tumor transplantation completely inhibited the growth of 6 of 11 tumors over a 12-week period, and histological evidence indicated that viable tumor was absent in the tissue remaining at the injection site. Lower doses (0.5 mCi) of 131I-labeled NP-4 inhibited tumor growth over 90% in comparison to untreated animals, but the tumors eventually resumed growth. Delaying the administration of radioantibody for 4 or 7 days after tumor transplantation significantly reduced the therapeutic efficacy. Although the same dose of 131I-labeled irrelevant immunoglobulin G also inhibited tumor growth, 131I-labeled NP-4 was generally 2-3 times more effective in reducing tumor growth than was the control IgG. There was a 13% loss in body weight within 7 days after treatment with 1 mCi, but all the animals regained their weight by day 14, indicating that the level of radioactivity was tolerated well. Dosimetric calculations predicted that over 14 days a dose of nearly 2400 rads was delivered to the tumors with 131I-labeled NP-4. These results confirm our previous studies that 131I-labeled antibody can effectively inhibit tumor growth, but suggest that radioantibody therapy is most effectively administered when there is a low tumor burden.

Limitations in testing for attitudes toward cancer.

A Cancer Attitude And Knowledge Questionnaire was administered to two groups of incoming first year medical students and to one of these groups at the end of their second year. The same questionnaire, except for the questions dealing with cognitive knowledge, was also used to assess the attitudes of practicing oncologists. There was a wide variation in the responses to the attitudinal items in all groups. In view of many inconsistencies in the results, a rigorous analysis of the instrument was carried out. The subscales derived from the Cancer Attitude Survey were found to lack adequate reliability. The only part of the attitudinal test found to be reliable and discriminatory was the semantic differential developed by the authors. It is, therefore, concluded that the currently used techniques are inadequate, and there is a need for a new multidimensional approach to the assessment of attitudes toward cancer.